TP53 gene expression was significantly decreased in CTCF-altered cancers (p = 0.0437, Supplementary Figure S3B), however, there was no significant difference after the exclusion of samples containing TP53 mutations from the analysis (Supplementary Figure S3C). This evidence concerns the gene CTCF and cancer.